microRNA let-7i-5p aggravates kidney fibrosis via targeting GALNT1

Chen-Min Sun1, Wen-Yi Zhang, Shu-Yan Wang

  • 1Department of Anesthesiology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Insights

MicroRNA let-7i-5p promotes renal fibrosis by decreasing GALNT1 expression and increasing inflammation. Overexpressing GALNT1 may counteract this inflammation, offering a potential therapeutic strategy for kidney fibrosis.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Biochemistry

Background:

  • Renal fibrosis is a significant health concern.
  • The role of microRNAs in kidney disease pathogenesis is increasingly recognized.

Purpose of the Study:

  • To investigate the role of microRNA let-7i-5p in renal fibrosis.
  • To identify and validate let-7i-5p targets in the context of kidney fibrosis.

Main Methods:

  • In silico analysis using the Mouse Kidney FibrOmics browser.
  • In vivo studies in mice models (unilateral ureteral obstruction and folic acid induction).
  • In vitro studies using transforming growth factor-β1-treated HK-2 cells, employing RT-PCR, Western blotting, and ELISA.

Main Results:

  • let-7i-5p expression increased while its target GALNT1 expression decreased in fibrotic kidney tissues.
  • Elevated levels of pro-inflammatory cytokines (IL-6, IL-1β, TNF-α) were observed in vivo.
  • In vitro, let-7i-5p overexpression inhibited GALNT1 and reduced inflammatory factor release.

Conclusions:

  • let-7i-5p plays a pro-fibrotic role by downregulating GALNT1 and promoting inflammation.
  • GALNT1 upregulation presents a potential therapeutic avenue against let-7i-5p-induced inflammation in renal fibrosis.